Medtech Group: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Medtech Group
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€211,920
2024 · -€11,136+€223,056
Equity
€12.3m
2024 · €12.0m+€211,920
Cash
€20,897
2024 · €5,102+€15,795
Balance sheet total
€22.0m
2024 · €21.3m+€748,040
Largest movements
Assets
- Financial fixed assets +€2.6m
up €2.6m (+15.3%), from €17.1m to €19.7m
of which Companies linked by participating interests: +€2.5m
- Receivables after one year -€1.8m
no longer reported in 2025 (was €1.8m)
Equity and liabilities
- Short-term financial debts +€456,863
up €456,863 (+5.1%), from €9.0m to €9.5m
Income statement
No income-statement line moved by more than 1% of the activity.
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€11,136
Other operating charges
+€3,321
Other operating items
+€446
Financial income
+€180,990
Financial charges
+€38,299
Result 2025
€211,920
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€2.2m
Investment
-€2.6m
Financing
+€456,863
Cash 2024
€5,102
From operations (derived)
+€2.2m
Net result for the year
+€211,920
Receivables after one year
+€1.8m
Receivables within one year
+€54,919
Trade debts
+€79,258
Investment (derived)
-€2.6m
Investment in fixed assets (net)
-€2.6m
Financing
+€456,863
Short-term financial debts
+€456,863
Cash 2025
€20,897
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €21,259,268 | €22,007,309 | +€748,040 | +3.5% |
| Fixed assets | 21/28 | €17,112,536 | €19,730,090 | +€2.6m | +15.3% |
| Financial fixed assets | 28 | €17,112,536 | €19,730,090 | +€2.6m | +15.3% |
| Affiliated companies | 280/1 | €13,073,232 | €13,073,232 | = | 0.0% |
| Participating interests | 280 | €13,073,232 | €13,073,232 | = | 0.0% |
| Companies linked by participating interests | 282/3 | €3,719,305 | €6,236,859 | +€2.5m | +67.7% |
| Participating interests | 282 | €3,719,305 | €6,236,859 | +€2.5m | +67.7% |
| Other financial fixed assets | 284/8 | €320,000 | €420,000 | +€100,000 | +31.3% |
| Shares | 284 | €320,000 | €420,000 | +€100,000 | +31.3% |
| Current assets | 29/58 | €4,146,732 | €2,277,218 | -€1.9m | -45.1% |
| Amounts receivable after more than one year | 29 | €1,830,390 | - | -€1.8m | |
| Other amounts receivable | 291 | €1,830,390 | - | -€1.8m | |
| Amounts receivable within one year | 40/41 | €2,311,241 | €2,256,322 | -€54,919 | -2.4% |
| Trade receivables | 40 | €125,676 | €262,634 | +€136,958 | +109.0% |
| Other amounts receivable | 41 | €2,185,565 | €1,993,687 | -€191,877 | -8.8% |
| Cash at bank and in hand | 54/58 | €5,102 | €20,897 | +€15,795 | +309.6% |
| Total equity and liabilities | 10/49 | €21,259,268 | €22,007,309 | +€748,040 | +3.5% |
| Equity | 10/15 | €12,043,802 | €12,255,722 | +€211,920 | +1.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | €12,025,202 | €12,237,122 | +€211,920 | +1.8% |
| Amounts payable | 17/49 | €9,215,467 | €9,751,587 | +€536,120 | +5.8% |
| Amounts payable within one year | 42/48 | €9,215,467 | €9,751,587 | +€536,120 | +5.8% |
| Financial debts | 43 | €9,046,367 | €9,503,230 | +€456,863 | +5.1% |
| Other loans | 439 | €9,046,367 | €9,503,230 | +€456,863 | +5.1% |
| Trade debts | 44 | €169,099 | €248,357 | +€79,258 | +46.9% |
| Suppliers | 440/4 | €169,099 | €248,357 | +€79,258 | +46.9% |
| Operating charges | 60/66A | €19,196 | €15,429 | -€3,767 | -19.6% |
| Services and other goods | 61 | €14,877 | €14,431 | -€446 | -3.0% |
| Other operating charges | 640/8 | €4,320 | €998 | -€3,321 | -76.9% |
| Operating profit (loss) | 9901 | -€19,196 | -€15,429 | +€3,767 | +19.6% |
| Financial income | 75/76B | €235,789 | €416,779 | +€180,990 | +76.8% |
| Recurring financial income | 75 | €235,789 | €416,779 | +€180,990 | +76.8% |
| Income from financial fixed assets | 750 | €3 | €234,472 | +€234,469 | +7350125.4% |
| Income from current assets | 751 | €235,786 | €182,307 | -€53,479 | -22.7% |
| Financial charges | 65/66B | €227,729 | €189,430 | -€38,299 | -16.8% |
| Recurring financial charges | 65 | €227,729 | €189,430 | -€38,299 | -16.8% |
| Debt charges | 650 | €226,939 | €188,609 | -€38,330 | -16.9% |
| Other financial charges | 652/9 | €790 | €821 | +€31 | +3.9% |
| Profit (loss) for the period before taxes | 9903 | -€11,136 | €211,920 | +€223,056 | |
| Profit (loss) for the period | 9904 | -€11,136 | €211,920 | +€223,056 | |
| Profit (loss) for the period to be appropriated | 9905 | -€11,136 | €211,920 | +€223,056 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.